miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1

Por Ke, Yang, Zhao, Weiyong, Xiong, Jie, Cao, Rubo
Publicado em 2013

The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients

Por Xia, Haiyan, Wen, Juan, Zhao, Weiyong, Gu, Dongying, Hu, Zhibin, Chen, Jinfei, Xu, Zhi
Publicado no Oncotarget (2017)

ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling

Por Yu, Shiyi, Zhang, Meng, Huang, Ling, Ma, Zhifang, Gong, Xue, Liu, Weiguang, Zhang, Jun, Chen, Liming, Yu, Zhenghong, Zhao, Weiyong, Liu, Yan
Publicado no Aging (Albany NY) (2019)

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer‐related pathways in breast cancer

Por Liu, Yan, Li, Jian, Ma, Zhifang, Zhang, Jun, Wang, Yuzhi, Yu, Zhenghong, Lin, Xue, Xu, Zhi, Su, Qian, An, Li, Zhou, Yehui, Ma, Xinxing, Yang, Yiwen, Wang, Feifei, Chen, Qingfei, Zhang, Yunchao, Wang, Jilinlin, Zheng, Huilin, Shi, Aihua, Yu, Shuang, Zhang, Jingzhong, Zhao, Weiyong, Chen, Liming
Publicado no Cancer Med (2019)